3. INTRODUCTION
•ESTABLISHED & BASED IN MUMBAI
•MANUFACTURERS OF FILTER FABRICS USED IN
PHARMACEUTICALS, CHEMICALS, DYES, PIGMENTS, MINING
COMPANIES
• CAPACITY OF PRODUCING 500000MTRS/DAY
•2 WORLD CLASS MANUFACTURING FACILITIES IN THANE.
• ABSOLUTE DOMESTIC MARKET LEADER.
• BACKED WITH DEALERS NETWORK ALL OVER INDIA
• COMPANY’S AVERAGE SALES GROWTH RATE SINCE ITS
INCEPTION IS 12.2%
6. Market Selection Criteria
PARAMETERS CHINA SOUTH USA
AFRICA
Market Size 5 4 5
Market Growth 3 5 3
Competitive Intensity High Low High
Entry Barriers Medium Low High
Foreign Relations 3 4 5
Industry Saturated Developing Developed
9. WHY SOUTH AFRICA
Politically stable
• Possess well-developed legal, communications, energy,
transport, and financial sectors; with a stock exchange that
ranks among the 10 largest in the world.
• Leading Recipient of FDI
• Investment Opportunities are high due to ample resources
in terms of land, labour & technology
10. WHY SOUTH AFRICA
According to our new research report "
South African Healthcare Market Analysis", the pharmaceutical industry
in South Africa has been continuously growing despite the concerns of drug
inflation. The pharmaceutical industry future remains pleasantly buoyant and it
is expected to grow at a CAGR of around 22% during 2010-2013. The optimistic
outlook for the industry is based on the fact that private players are making
intensive investments.
Our Clientile has done huge investments in South Africa.
e.g.Cipla Ltd, Lupin Ltd, GSK, Eli & Lilly etc
11. WHY SOUTH AFRICA
INCREASING GDP
PROJECTS PRONE
South Africa led the subregion as foreign direct investment (FDI)
inflows into sub-Saharan Africa jumped by 25% in 2011, according
to the 2012 World Investment Report by the UN Conference on
Trade and Development (Unctad).
The report, released in Geneva, Switzerland on Thursday, shows
that FDI inflows to sub-Saharan Africa soared from US$29.5-billion
in 2010 to $36.9-billion in 2011, a level comparable to the peak of
$37.3-billion achieved in 2008, prior to the onset of the global
financial crisis.
http://www.southafrica.info/business/investing/fdi-
060712.htm#.UIf0Rq5lV8U#ixzz2AE0cereC
12. ENTRY STRATEGY
DEALERSHIPS / FRANCHISING
1. Will provide marketing & technical know how to the
dealers in SA
2. Distribute the market among dealers geographically
3. Exclusive Dealers only
4. Dealers will be the small & local suppliers of filter fabrics
to pharma companies
5. Commissions based dealership.
13. SEGMENTATION STRATEGY
The market will be segmented geographically so
that it will be easy for a dealer to supply the
products in right time.
15. PRICING STRATEGY
Products will be priced reasonably low to penetrate
into the market
The main objective will be to keep new entrants away
from the industry
In case of highly innovative product, the premium
will be charged.
